Evidence map›Paper›PMID 15229244›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders.

Elena Klenova, Alison C Scott, Julian Roberts, Shaharum Shamsuddin, Elizabeth A Lovejoy, Stephan Bergmann, Vivien J Bubb, Hans-Dieter Royer, John P Quinn

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Does CTCF mediate between nuclear organization and gene expression?BioEssays : news and reviews in molecular, cellular and developmental biology · 2010
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Elena KlenovaDepartment of Biological Sciences, University of Essex, Essex CO4 3SQ, United Kingdom. klenovae@essex.ac.uk
Alison C Scott
Julian Roberts
Shaharum Shamsuddin
Elizabeth A Lovejoy
Stephan Bergmann
Vivien J Bubb
Hans-Dieter Royer
John P Quinn
University of Essex · GBCenter of Advanced European Studies and Research · DEMemorial Sloan Kettering Cancer Center · USUniversity of Liverpool · GB

Funding

Breast Cancer Now 2000:137Wellcome Trust
6 · The paper itself

Abstract

The serotonin transporter (5-HTT) gene contains a variable number tandem repeat (VNTR) domain within intron 2 that is often associated with a number of neurological conditions, including affective disorders. The implications of this polymorphism are not yet understood, however, we have previously demonstrated that the 5-HTT VNTR is a transcriptional regulatory domain, and the allelic variation supports differential reporter gene expression in vivo and in vitro. The aim of this study was to identify transcription factors responsible for the regulation of this VNTR. Using a yeast one-hybrid screen, we found the transcription factor Y box binding protein 1 (YB-1) interacts with the 5-HTT VNTR. Consistent with this, we demonstrate in a reporter gene assay that the polymorphic VNTR domains differentially respond to exogenous YB-1 and that YB-1 will bind to the VNTR in vitro in a sequence-specific manner. Interestingly, the transcription factor CCTC-binding factor (CTCF), previously shown to interact with YB-1, interferes with the ability of the VNTR to support YB-1-directed reporter gene expression. In addition, CTCF blocks the binding of YB-1 to its DNA recognition sequences in vitro, thus providing a possible mechanism of regulation of YB-1 activation of the VNTR by CTCF. Therefore, we have identified YB-1 and CTCF as transcription factors responsible, at least in part, for modulation of VNTR function as a transcriptional regulatory domain. Our data suggest a novel mechanism that explains, in part, the ability of the distinct VNTR copy numbers to support differential reporter gene expression based on YB-1 binding sites.

Indexed as

Minisatellite RepeatsAllelesAnimalsBinding SitesCCCTC-Binding FactorCell LineChickensChlorocebus aethiopsCOS CellsDNA-Binding ProteinsDNA, ComplementaryGene Expression RegulationGenes, ReporterHumansIntronsKidneyCCCTC-Binding FactorCTCF protein, humanDNA-Binding ProteinsDNA, ComplementaryMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsNuclear ProteinsRecombinant Fusion ProteinsRepressor ProteinsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, humanTranscription FactorsY-Box-Binding Protein 1YBX1 protein, human

Identifiers

PMID15229244
PMCPMC6729234
OpenAlexW2057597572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.